Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.-论文-万方医学网

第一作者： Wenlin,Ren

第一单位： AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China.

作者： Wenlin,Ren ^[1] ; Hunter,Sun ^[2] ; George F,Gao ^[3] ; Jianxin,Chen ^[4] ; Sean,Sun ^[2] ; Rongqing,Zhao ^[2] ; Guang,Gao ^[2] ; Yalin,Hu ^[5] ; Gan,Zhao ^[6] ; Yuxin,Chen ^[7] ; Xia,Jin ^[8] ; Feng,Fang ^[1] ; Jinggong,Chen ^[4] ; Qi,Wang ^[1] ; Sitao,Gong ^[1] ; Wen,Gao ^[4] ; Yufei,Sun ^[2] ; Junchi,Su ^[2] ; Ailiang,He ^[4] ; Xin,Cheng ^[6] ; Min,Li ^[8] ; Chenxi,Xia ^[1] ; Maohua,Li ^[9] ; Le,Sun ^[10]

作者单位： AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China. ^[1] AnyGo Technology Co., LTD, D1117 Xinhua International Plaza, 89 Dayangfan Rd, Beijing, China. ^[2] Institute of Microbiology Chinese Academy of Sciences, China. ^[3] ZhenGe Biotechnology Co., LTD, Shanghai, China. ^[4] SinoVac, Beijing, China. ^[5] Advaccine (Suzhou) Biopharmaceuticals, Co., LTD, Suzhou, Jiangsu, China. ^[6] Dept. Lab Medine, Nanjing Univ. Medical School, Nanjing, Jiangsu 210008, China. ^[7] College of Public Health, Fudan Univ., Shanghai, China. ^[8] AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China. Electronic address: limh@antibodychina.com. ^[9] AnyGo Technology Co., LTD, D1117 Xinhua International Plaza, 89 Dayangfan Rd, Beijing, China; AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing 101111, China. Electronic address: sunl@antibodychina.com. ^[10]

医学主题词动物(Animals);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);CHO细胞(CHO Cells);冠状病毒感染(Coronavirus Infections);仓鼠属(Cricetulus);女(雌)性(Female);HEK293细胞(HEK293 Cells);人类(Humans);免疫法, 被动(Immunization, Passive);免疫球蛋白Fc片段(Immunoglobulin Fc Fragments);免疫球蛋白G(Immunoglobulin G);免疫球蛋白M(Immunoglobulin M);猕猴属(Macaca);男(雄)性(Male);小鼠(Mice);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);兔(Rabbits);病毒疫苗(Viral Vaccines)

DOI 10.1016/j.vaccine.2020.06.066

PMID 32651113

发布时间 2024-12-07

检索历史清除

Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

检索历史清除